Trastuzumab Deruxtecan Fails to Show Added Benefit in Breast Cancer Patients
NICE Endorses Lorlatinib for Untreated ALK-Positive Lung Cancer
Zutectra Proves Crucial in Preventing Hepatitis B Re-Infection Post-Transplant
Advancing Surgical Training with Immersive VR Platforms
Germany Tasks IQWiG to Assess Interatrial Shunt for Heart Failure Treatment
Upcoming Transparency Council Meeting Engages Critical Discussions on Healthcare Regulations
Iran Faces Complex Barriers in Implementing Health Technology Assessments
NICE Embraces Comprehensive Carer HRQoL in Health Technology Assessments
IQWiG Evaluates Percutaneous Shunt for Heart Failure Treatment
Remote Monitoring Enhances Pancreatectomy Recovery
Profiling Tests Provide Insight into Breast Cancer Chemotherapy Decisions
IQWiG Assesses Impact of High Frequency Endometrial Ablation on Menorrhagia
Radiotherapy Innovations Categorized to Enhance Appraisal Framework
U.S. Drug Pricing: Inside the Cost and Value Conundrum
Guidance for Using Decision Thresholds in GRADE Framework Advances Health Outcomes Assessment


